Saturday, April 1, 2023
Dent News Europe
  • Home
  • Dentistry
  • Endodontist
  • Implantology
  • Orthodontics
  • Periodontology
  • Prosthodontics
No Result
View All Result
  • Home
  • Dentistry
  • Endodontist
  • Implantology
  • Orthodontics
  • Periodontology
  • Prosthodontics
No Result
View All Result
HealthNews
No Result
View All Result
Home Implantology

Xlife Sciences AG: curasan AG and Xlife Sciences AG Cooperate in the Field of Regenerative Medicine

DNWS by DNWS
June 25, 2021
in Implantology
0
Xlife Sciences AG: curasan AG and Xlife Sciences AG Cooperate in the Field of Regenerative Medicine
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter


ZUERICH, SWITZERLAND / ACCESSWIRE / June 16, 2021 / curasan AG, a number one world supplier of biomaterials for bone and tissue regeneration in dental and orthopedic surgical procedure, and Xlife Sciences AG have initiated a collaboration within the discipline of regenerative medication. Beneath the settlement it’s meant to develop, produce, certify and market new merchandise with a give attention to the musculoskeletal space and tissue regeneration.

The primary emphasis of the collaboration lies on the biologization of bone substitute supplies and the event of an modern manufacturing course of. On this context, on the one hand, bone substitute merchandise are to be manufactured utilizing 3D printing processes by a mission firm of Xlife Sciences AG. The primary collection of exams have already yielded promising outcomes. Alternatively, service supplies are to be optimized for improved biofunctionality with substances that promote bone progress. For this function, new kinds of modalities, so-called exosomes, are launched into the bone substitute materials. Exosomes are bioactive nanoparticles which are secreted by stem cells or obtained from human platelets; these include, amongst different molecules, progress components and microRNAs.

“The cooperation with Xlife Sciences AG and its mission firms offers curasan entry to probably the most trendy manufacturing processes in addition to promising new therapies in musculoskeletal regeneration. Specifically, using exosomes along side the tried and examined curasan merchandise has monumental potential in tissue regeneration, “says Dirk Dembski, CEO of curasan AG. The Exosome Market recorded gross sales of roughly $ 174.04M in 2020 and is anticipated to expertise a CAGR (Common Annual Development Charge) of 27.89% over the forecast interval (2021-2026) *

*Supply: https://www.mordorintelligence.com/industry-reports/exosomes-market

About Xlife Sciences AG

Xlife Sciences AG is a Swiss firm with give attention to investing in promising applied sciences within the life science trade. Xlife Sciences AG is constructing the bridge from analysis and growth to healthcare markets by supporting researchers and entrepreneurs in positioning, structuring, creating and implementing their ideas. Along with industrial companions or universities, Xlife Sciences AG leads tasks by the proof-of-concept section after an invention disclosure or start-up. Subsequently, the agency focuses on out-licensing or promoting the corporate, typically with a mix of a strategic partnership. Xlife Sciences AG affords its traders direct entry to the additional growth of modern and future-oriented applied sciences at a really early stage.

For extra info, please go to: www.xlifesciences.ch

About curasan AG

curasan develops, produces and markets biomaterials and medical gadgets for bone and tissue regeneration.

As a world expertise chief within the future-oriented progress market of regenerative medication, our firm is specialised in biomimetic bone grafting supplies mimicking organic constructions for the use in orthopedics, traumatology, backbone surgical procedure and dental implantology.

Additional info: https://www.curasan.de/en/company/about-us/

For media inquiries:

Dennis Lennartz, Head Investor Relations, Xlife Sciences AG, Tel. +41 44 385 84 60, dennis.lennartz@xlifesciences.ch

Andrea Weidner, Company Communications, curasan AG, Tel. +49 6027 40 900 51, pr@curasan.com

For scientific inquiries:

Dr. Frank Plöger, Chief Scientific Officer, Xlife Sciences AG, Tel. +41 44 385 84 62, frank.ploeger@xlifesciences.ch

SOURCE: Xlife Sciences AG


View supply model on accesswire.com:

https://www.accesswire.com/651921/Xlife-Sciences-AG-curasan-AG-and-Xlife-Sciences-AG-Cooperate-in-the-Field-of-Regenerative-Medicine



Source link

Advertisement Banner
Previous Post

Loudoun Orthodontics | loudountimes.com

Next Post

Global Dental Caries and Endodontic Market 2021 High Growth Prediction due to Increasing Demand and Future Trends

DNWS

DNWS

Next Post
Global Orthodontic Headgear Market 2021 Outlook, Demand, Regional Analysis, Industry Value Chain Study Report

Global Dental Caries and Endodontic Market 2021 High Growth Prediction due to Increasing Demand and Future Trends

Recent Posts

  • Restorative Dentistry Market Size, Scope, Forecast to 2029
  • Endodontic File Market Size 2021 Analysis by Top Key Players
  • Orthodontic Equipment and Consumables Consumption Market Size 2021 Analysis by Top Key Players
  • Top Dentists of the Twin Cities, 2022
  • Rivet Machines Market Regional Growth, Growing Demand, Competition, Investment Opportunities & Forecast 2028 – Industrial IT

Categories

  • Dentistry
  • Eastern Europe
  • Endodontist
  • Implantology
  • Orthodontics
  • Periodontology
  • Prosthodontics
  • Privacy & Policy
  • About Us
  • Contact Us

© 2021 Copyright dentnews

No Result
View All Result
  • Home
  • Dentistry
  • Endodontist
  • Implantology
  • Orthodontics
  • Periodontology
  • Prosthodontics

© 2021 Copyright dentnews